Anke van den Berg
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Papers in
- Cancer Research 103
- MicroRNA in disease regulation 40
- Cancer-related molecular mechanisms research 38
- Cancer Genomics and Diagnostics 37
-
- Lymphoma Diagnosis and Treatment 108
- Co-authors
- CDM FletcherIneke MolenaarSibrand PoppemaJoost KluiverArjan DiepstraBart‐Jan KroesenLydia VisserS Poppema
- Journals
- Blood (29 papers)PLoS ONE (19 papers)Cancers (16 papers)Genes Chromosomes and Cancer (13 papers)The Journal of Pathology (11 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Anke van den Berg
349 papers receiving 18.9k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Cancer Research 5.3k
- Pathology and Forensic Medicine 4.3k
- Oncology 5.6k
- Pulmonary and Respiratory Medicine 4.8k
- Immunology 2.9k
Countries citing papers authored by Anke van den Berg
This map shows the geographic impact of Anke van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke van den Berg more than expected).
Fields of papers citing papers by Anke van den Berg
This network shows the impact of papers produced by Anke van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke van den Berg. The network helps show where Anke van den Berg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anke van den Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2020 | 9 | |
| 5 | 2019 | 29 | |
| 6 | 2019 | 16 | |
| 7 | 2018 | 29 | |
| 8 | 2017 | 51 | |
| 9 | 2014 | 34 | |
| 10 | Inhibition of Fc gamma R-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and Fc gamma RIIb in human macrophages | 2014 | 1 |
| 11 | Improving fluorescence-guided sentinel node detection during robot-assisted laparoscopic sentinel node biopsy for prostate cancer | 2014 | 1 |
| 12 | Die diversiteit van Suid-Afrikaanse spinnekoppe (Arachnida: Araneae): Dokumentering van ’n nasionale opname | 2013 | 4 |
| 13 | Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma | 2012 | 2 |
| 14 | Ownership of Minerals Under the New Legislative Framework for Mineral Resources | 2009 | 1 |
| 15 | RASSF1A and SCGB3A1 are common target genes for promoter hypermethylation in malignant peripheral nerve sheath tumors | 2007 | 1 |
| 16 | 2006 | 26 | |
| 17 | Multidrug resistance proteins in primary and metastatic soft-tissue sarcomas: down-regulation of P-glycoprotein during metastatic progression. | 2004 | 7 |
| 18 | Multiple Equilibria and Minimum Wages in Labor Markets with Informational Frictions and Heterogeneous Production Technologies | 2003 | 14 |
| 19 | Identification of chromosomal copy number changes associated with transformation of follicular to diffuse large cell lymphoma. | 2002 | 0 |
| 20 | Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. | 1998 | 79 |
About Anke van den Berg
Anke van den Berg is a scholar working on Cancer Research, Pathology and Forensic Medicine, Immunology, Oncology and Genetics, having authored 364 papers that have together received 19.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (108 papers), Immune Cell Function and Interaction (50 papers), MicroRNA in disease regulation (40 papers), Cancer-related molecular mechanisms research (38 papers), Cancer Genomics and Diagnostics (37 papers), Viral-associated cancers and disorders (37 papers), RNA modifications and cancer (32 papers) and Renal and related cancers (32 papers). The work is most often cited by research in Cancer Research (5.3k citations), Pathology and Forensic Medicine (4.3k citations), Oncology (5.6k citations), Pulmonary and Respiratory Medicine (4.8k citations) and Immunology (2.9k citations). Anke van den Berg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include CDM Fletcher, Ineke Molenaar, Sibrand Poppema, Joost Kluiver, Arjan Diepstra, Bart‐Jan Kroesen, Lydia Visser, S Poppema, Klaas Kok and Debora de Jong. Their work appears in journals such as Blood, PLoS ONE, Cancers, Genes Chromosomes and Cancer and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.